ArticlePharmacoEconomics2020

Cost-Effectiveness of Tofacitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis in China.

Lei Tian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.